with Clinical Manifestations

The ACR Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient’s clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient’s condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the FDA have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination.

[1]  K. Ellenbogen,et al.  Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[2]  Daniel S. Cormican,et al.  Ultrasonic Enhancing Agents for the Cardiothoracic Anesthesiologist: A Focused Review of the 2018 American Society of Echocardiography Guidelines Update. , 2019, Journal of cardiothoracic and vascular anesthesia.

[3]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.

[4]  J. Leipsic,et al.  ACR Appropriateness Criteria® Suspected New-Onset and Known Nonacute Heart Failure. , 2018, Journal of the American College of Radiology : JACR.

[5]  J. Moon,et al.  Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease , 2018, Heart.

[6]  R. Manka,et al.  Approximation of the Incidence of Myocarditis by Systematic Screening With Cardiac Magnetic Resonance Imaging. , 2018, JACC. Heart failure.

[7]  Jeroen J. Bax,et al.  International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management , 2018, European heart journal.

[8]  Jeroen J. Bax,et al.  International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology , 2018, European heart journal.

[9]  Harald Becher,et al.  Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update. , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[10]  Lazaro E Hernandez Myocardial stress perfusion magnetic resonance in children with hypertrophic cardiomyopathy , 2018, Cardiology in the Young.

[11]  A. Henning,et al.  Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy , 2017, Circulation.

[12]  D. Gohn,et al.  Real-World Evaluation of Magnetic Resonance Imaging in Patients With a Magnetic Resonance Imaging Conditional Pacemaker System: Results of 4-Year Prospective Follow-Up in 2,629 Patients. , 2017, JACC. Clinical electrophysiology.

[13]  J. Zamorano,et al.  Left Ventricular Global Strain Analysis by Two‐Dimensional Speckle‐Tracking Echocardiography: The Learning Curve , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  R. Manka,et al.  Cardiac Magnetic Resonance Imaging in Myocarditis Reveals Persistent Disease Activity Despite Normalization of Cardiac Enzymes and Inflammatory Parameters at 3-Month Follow-Up , 2017, Circulation. Heart failure.

[15]  Richard B. Thompson,et al.  Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) , 2017, Journal of Cardiovascular Magnetic Resonance.

[16]  P. Rajiah,et al.  Computed tomography of cardiomyopathies. , 2017, Cardiovascular diagnosis and therapy.

[17]  E. Braunwald,et al.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. , 2017, Circulation research.

[18]  B. Maron,et al.  Classification, Epidemiology, and Global Burden of Cardiomyopathies. , 2017, Circulation research.

[19]  Birgitta K. Velthuis,et al.  Feature tracking CMR reveals abnormal strain in preclinical arrhythmogenic right ventricular dysplasia/ cardiomyopathy: a multisoftware feasibility and clinical implementation study , 2017, Journal of Cardiovascular Magnetic Resonance.

[20]  R. Herfkens,et al.  Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis , 2017, Clinical nuclear medicine.

[21]  H. Heidbuchel,et al.  2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. , 2017, Heart rhythm.

[22]  P. Thavendiranathan,et al.  Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies. , 2017, Revista espanola de cardiologia.

[23]  Richard D. White,et al.  ACR Appropriateness Criteria® Dyspnea-Suspected Cardiac Origin. , 2017, Journal of the American College of Radiology : JACR.

[24]  E. Nagel,et al.  T1 and T2 Mapping in Recognition of Early Cardiac Involvement in Systemic Sarcoidosis. , 2017, Radiology.

[25]  N. Tamaki,et al.  Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study , 2017, European Radiology.

[26]  Jason C. Rubenstein,et al.  Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator , 2017, New England Journal of Medicine.

[27]  M. Xie,et al.  Incremental value of contrast echocardiography in the diagnosis of left ventricular noncompaction , 2016, Frontiers of Medicine.

[28]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.

[29]  P. Rajiah,et al.  Update on the Role of Cardiac Magnetic Resonance in Acquired Nonischemic Cardiomyopathies , 2016, Journal of thoracic imaging.

[30]  K. Sliwa,et al.  Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy , 2016, European journal of heart failure.

[31]  I. M. Pereira,et al.  Analysis of Regional Left Ventricular Strain in Patients with Chagas Disease and Normal Left Ventricular Systolic Function. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  P. Rajiah,et al.  Utility of late gadolinium enhancement in pediatric cardiac MRI , 2016, Pediatric Radiology.

[33]  J. Moon,et al.  Cardiac MRI evaluation of myocardial disease , 2016, Heart.

[34]  Q. Fang,et al.  Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis , 2016, BMC Cardiovascular Disorders.

[35]  Stefan L. Zimmerman,et al.  Right ventricular strain by MR quantitatively identifies regional dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy , 2016, Journal of magnetic resonance imaging : JMRI.

[36]  D. Vargas,et al.  Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management. , 2016, Radiographics : a review publication of the Radiological Society of North America, Inc.

[37]  Thor Edvardsen,et al.  Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia , 2016, European heart journal cardiovascular Imaging.

[38]  P. Soman,et al.  Radionuclide Imaging Applications in Cardiomyopathies and Heart Failure , 2016, Current Cardiology Reports.

[39]  H. Lee,et al.  Myocardial Extracellular Volume Fraction with Dual-Energy Equilibrium Contrast-enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MR Imaging. , 2016, Radiology.

[40]  Pawan K Gupta,et al.  Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis. , 2015, Heart rhythm.

[41]  C. Rochitte,et al.  Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance , 2015, Journal of Cardiovascular Magnetic Resonance.

[42]  S. Punwani,et al.  Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis , 2015, Journal of cardiovascular computed tomography.

[43]  P. Kellman,et al.  Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2015, Circulation.

[44]  N. Smedira,et al.  Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography. , 2015, Circulation. Cardiovascular imaging.

[45]  R. Underwood,et al.  Cardiac sarcoidosis: diagnosis and management , 2015, Postgraduate Medical Journal.

[46]  M. Maron The role of cardiovascular magnetic resonance in sudden death risk stratification in hypertrophic cardiomyopathy. , 2015, Cardiac electrophysiology clinics.

[47]  S. K. White,et al.  Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload , 2015, Journal of magnetic resonance imaging : JMRI.

[48]  B. Wong,et al.  Myocardial Fibrosis Burden Predicts Left Ventricular Ejection Fraction and Is Associated With Age and Steroid Treatment Duration in Duchenne Muscular Dystrophy , 2015, Journal of the American Heart Association.

[49]  S. Gabriel,et al.  Cardiorheumatology: cardiac involvement in systemic rheumatic disease , 2015, Nature Reviews Cardiology.

[50]  A. Luciani,et al.  Noninvasive detection of cardiac amyloidosis using delayed enhanced MDCT: a pilot study , 2015, European Radiology.

[51]  S. K. White,et al.  Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance , 2014, Journal of Cardiovascular Magnetic Resonance.

[52]  Martin Borggrefe,et al.  [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.

[53]  J. Hanmer,et al.  Cardiovascular magnetic resonance characterization of left ventricular non-compaction provides independent prognostic information in patients with incident heart failure or suspected cardiomyopathy , 2014, Journal of Cardiovascular Magnetic Resonance.

[54]  G. Feuchtner,et al.  Quantification of myocardial delayed enhancement and wall thickness in hypertrophic cardiomyopathy: multidetector computed tomography versus magnetic resonance imaging. , 2014, European journal of radiology.

[55]  Tevfik F Ismail,et al.  Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study , 2014, Journal of Cardiovascular Magnetic Resonance.

[56]  V. Fuster,et al.  The MOGE(S) classification of cardiomyopathy for clinicians. , 2014, Journal of the American College of Cardiology.

[57]  D. Bluemke,et al.  Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update , 2014, Journal of Cardiovascular Magnetic Resonance.

[58]  Paaladinesh Thavendiranathan,et al.  Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. , 2014, Journal of the American College of Cardiology.

[59]  E. Omerovic,et al.  Takotsubo triggered by acute myocardial infarction: a common but overlooked syndrome? , 2014, Journal of geriatric cardiology : JGC.

[60]  W. Shimizu,et al.  Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis , 2014, Heart.

[61]  A. Nemes,et al.  Left Ventricular Strain Reduction Is Not Confined to the Noncompacted Segments in Noncompaction Cardiomyopathy–Insights from the Three‐Dimensional Speckle Tracking Echocardiographic MAGYAR‐Path Study , 2014, Echocardiography.

[62]  P. Matthews,et al.  Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis – a clinical study using myocardial T1-mapping and extracellular volume quantification , 2014, Journal of Cardiovascular Magnetic Resonance.

[63]  Derliz Mereles,et al.  Quantitative analysis of left ventricular strain using cardiac computed tomography. , 2014, European journal of radiology.

[64]  L. Afonso,et al.  Cardiac Magnetic Resonance Imaging in Peripartum Cardiomyopathy , 2014, The American journal of the medical sciences.

[65]  L. Anderson,et al.  CMR-based differentiation of AL and ATTR cardiac amyloidosis. , 2014, JACC. Cardiovascular imaging.

[66]  Daniel B Ennis,et al.  Device artifact reduction for magnetic resonance imaging of patients with implantable cardioverter-defibrillators and ventricular tachycardia: late gadolinium enhancement correlation with electroanatomic mapping. , 2014, Heart rhythm.

[67]  K. Klingel,et al.  Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis , 2014, Journal of Cardiovascular Magnetic Resonance.

[68]  W. Burchert,et al.  Hypertrophic cardiomyopathy in cardiac CT: a validation study on the detection of intramyocardial fibrosis in consecutive patients , 2014, The International Journal of Cardiovascular Imaging.

[69]  Ashley M. Lee,et al.  Defining Left Ventricular Noncompaction Using Cardiac Computed Tomography , 2014, Journal of thoracic imaging.

[70]  S. Flamm,et al.  Cardiac MRI in the Assessment of Cardiac Injury and Toxicity From Cancer Chemotherapy: A Systematic Review , 2013, Circulation. Cardiovascular imaging.

[71]  Marmar Vaseghi,et al.  Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devices. , 2013, Radiology.

[72]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[73]  G. Gladish,et al.  Cardiac complications of oncologic therapy. , 2013, Radiographics : a review publication of the Radiological Society of North America, Inc.

[74]  Stefan Neubauer,et al.  T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. , 2013, JACC. Cardiovascular imaging.

[75]  Katja Zeppenfeld,et al.  Contrast-Enhanced MRI–Derived Scar Patterns and Associated Ventricular Tachycardias in Nonischemic Cardiomyopathy: Implications for the Ablation Strategy , 2013, Circulation. Arrhythmia and electrophysiology.

[76]  W. Hundley,et al.  Comparison of systolic and diastolic criteria for isolated LV noncompaction in CMR. , 2013, JACC. Cardiovascular imaging.

[77]  D. Pennell,et al.  Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. , 2013, Circulation.

[78]  A. Freeman,et al.  Predictors of cardiac sarcoidosis using commonly available cardiac studies. , 2013, The American journal of cardiology.

[79]  N. Hagiwara,et al.  Utility of ECG-gated MDCT to differentiate patients with ARVC/D from patients with ventricular tachyarrhythmias. , 2013, Journal of cardiovascular computed tomography.

[80]  G. Sanz,et al.  Myocardial involvement in Chagas disease: insights from cardiac magnetic resonance. , 2013, International journal of cardiology.

[81]  I. Rinta-Kiikka,et al.  Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer. , 2013, Journal of the American College of Cardiology.

[82]  U. Kramer,et al.  CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. , 2013, JACC. Cardiovascular imaging.

[83]  M. Robson,et al.  Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.

[84]  Reza Razavi,et al.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.

[85]  Xiaohai Ma,et al.  Assessment of myocardial fibrosis and coronary arteries in hypertrophic cardiomyopathy using combined arterial and delayed enhanced CT: comparison with MR and coronary angiography , 2013, European Radiology.

[86]  Tevfik F Ismail,et al.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.

[87]  W. Edwards,et al.  Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation. , 2013, AJR. American journal of roentgenology.

[88]  M. Friedrich,et al.  Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols , 2013, The International Journal of Cardiovascular Imaging.

[89]  J. Hoffmann,et al.  Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies , 2012, European Radiology.

[90]  M. Robson,et al.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[91]  James D. Thomas,et al.  Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis , 2012, Heart.

[92]  Bernd Hamm,et al.  Head-to-head comparison of left ventricular function assessment with 64-row computed tomography, biplane left cineventriculography, and both 2- and 3-dimensional transthoracic echocardiography: comparison with magnetic resonance imaging as the reference standard. , 2012, Journal of the American College of Cardiology.

[93]  D. Bluemke,et al.  Trabeculated (non-compacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis , 2012, Journal of Cardiovascular Magnetic Resonance.

[94]  T. Kristensen,et al.  Accuracy of multi-slice computed tomography for measurement of left ventricular ejection fraction compared with cardiac magnetic resonance imaging and two-dimensional transthoracic echocardiography: a systematic review and meta-analysis. , 2012, European Journal of Radiology.

[95]  C. Hasdemir,et al.  Late Gadolinium Enhancement CMR in Patients with Tachycardia‐Induced Cardiomyopathy Caused by Idiopathic Ventricular Arrhythmias , 2012, Pacing and clinical electrophysiology : PACE.

[96]  R. Cury,et al.  Cardiac MR Imaging of Nonischemic Cardiomyopathies: Imaging Protocols and Spectra of Appearances. , 2012, Radiology.

[97]  M. Maron,et al.  Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy , 2012, Journal of Cardiovascular Magnetic Resonance.

[98]  Robert A. deKemp,et al.  The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience , 2012, The Journal of Nuclear Medicine.

[99]  A. Sato,et al.  The clinical impact of late gadolinium enhancement in Takotsubo cardiomyopathy: serial analysis of cardiovascular magnetic resonance images , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[100]  R. Dietz,et al.  New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging. , 2011, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[101]  J. Fishman,et al.  Takotsubo cardiomyopathy: utility of cardiac computed tomography angiography for acute diagnosis. , 2011, Journal of thoracic imaging.

[102]  G. Schuler,et al.  Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. , 2011, JAMA.

[103]  P. Rusconi,et al.  Danon disease: characteristic late gadolinium enhancement pattern on cardiac magnetic resonance imaging , 2011, Cardiology in the Young.

[104]  Vasken Dilsizian,et al.  American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomograph , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[105]  Raymond J Kim,et al.  Late Gadolinium Enhancement Magnetic Resonance Imaging in the Diagnosis and Prognosis of Endomyocardial Fibrosis Patients , 2011, Circulation. Cardiovascular imaging.

[106]  J. Schulz-Menger,et al.  Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis , 2011, European Radiology.

[107]  Jeroen J. Bax,et al.  Feasibility of diastolic function assessment with cardiac CT: feasibility study in comparison with tissue Doppler imaging. , 2011, JACC. Cardiovascular imaging.

[108]  A. Ghandforoush,et al.  Viability assessment by multidetector computed tomography in Takotsubo cardiomyopathy. , 2011, Journal of thoracic imaging.

[109]  Eckart Fleck,et al.  Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.

[110]  David A Bluemke,et al.  MRI of nonischemic cardiomyopathy. , 2010, AJR. American journal of roentgenology.

[111]  K. Sliwa,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy , 2010, European journal of heart failure.

[112]  J. Wansapura,et al.  Detection of progressive cardiac dysfunction by serial evaluation of circumferential strain in patients with Duchenne muscular dystrophy. , 2010, The American journal of cardiology.

[113]  Gilbert Habib,et al.  Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. , 2010, European heart journal.

[114]  J. Seward,et al.  Infiltrative cardiovascular diseases: cardiomyopathies that look alike. , 2010, Journal of the American College of Cardiology.

[115]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.

[116]  F. Thuny,et al.  Assessment of left ventricular non-compaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography. , 2010, Archives of cardiovascular diseases.

[117]  M. Ishihara,et al.  Prevalence of incidental coronary artery disease in tako-tsubo cardiomyopathy , 2009, Coronary artery disease.

[118]  A. Del Maschio,et al.  Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. , 2009, AJR. American journal of roentgenology.

[119]  D. Pennell,et al.  Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[120]  Matthew W. Martinez,et al.  Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. , 2008, International journal of cardiology.

[121]  M. Nishimura,et al.  Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[122]  N. Kelekis,et al.  Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. , 2007, Arthritis and rheumatism.

[123]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[124]  R. Cury,et al.  Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity. , 2007, AJR. American journal of roentgenology.

[125]  Mario J. Garcia,et al.  Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy , 2007, Heart.

[126]  D. Andreini,et al.  Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[127]  J. Serfaty,et al.  Diagnostic value of ECG-gated multidetector computed tomography in the early phase of suspected acute myocarditis. A preliminary comparative study with cardiac MRI , 2007, European Radiology.

[128]  K. Klingel,et al.  Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.

[129]  R. Hruban,et al.  Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. , 2004, American heart journal.

[130]  C H Lorenz,et al.  Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.

[131]  D N Firmin,et al.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.

[132]  F. Follath,et al.  Nonischemic heart failure: epidemiology, pathophysiology, and progression of disease. , 1999, Journal of cardiovascular pharmacology.

[133]  A. Tajik,et al.  Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis. , 1996, Circulation.

[134]  C. Morillo,et al.  Recommendations for Multimodality Cardiac Imaging in Patients with Chagas Disease: A Report from the American Society of Echocardiography in Collaboration With the InterAmerican Association of Echocardiography (ECOSIAC) and the Cardiovascular Imaging Department of the Brazilian Society of Cardiology , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[135]  R. Coulden,et al.  Cardiac magnetic resonance assessment of takotsubo cardiomyopathy. , 2016, Clinical radiology.

[136]  E. Nagel,et al.  T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. , 2016, JACC. Cardiovascular imaging.

[137]  S. Kaste,et al.  ACR – NASCI – SIR – SPR PRACTICE PARAMETER FOR THE PERFORMANCE AND INTERPRETATION OF BODY COMPUTED TOMOGRAPHY ANGIOGRAPHY , 2016 .

[138]  Jonathan R. Weir-McCall,et al.  Left Ventricular Noncompaction Anatomical Phenotype or Distinct Cardiomyopathy ? , 2016 .

[139]  Chagas disease in Latin America: an epidemiological update based on 2010 estimates. , 2015, Releve epidemiologique hebdomadaire.

[140]  J. Stockman,et al.  A Prospective Evaluation of a Protocol for Magnetic Resonance Imaging of Patients With Implanted Cardiac Devices , 2013 .

[141]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[142]  H. Sakuma,et al.  Prevalence and signal characteristics of late gadolinium enhancement on contrast-enhanced magnetic resonance imaging in patients with takotsubo cardiomyopathy. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[143]  P. Sanders,et al.  Cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis: presenting as ventricular tachycardia. , 2011, Texas Heart Institute journal.

[144]  S. Raman,et al.  Advances in Cardiovascular Imaging Cardiac Involvement in Patients With Muscular Dystrophies Magnetic Resonance Imaging Phenotype and Genotypic Considerations , 2011 .

[145]  P. Nihoyannopoulos,et al.  Restrictive cardiomyopathies. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[146]  J. Bogaert,et al.  Nonischemic Myocardial Disease , 2005 .

[147]  H. Fleming Cardiac sarcoidosis. , 1986, Clinics in dermatology.